AGRX logo

Agile Therapeutics (AGRX) Working Capital

Annual Working Capital

-$11.25 M
-$9.22 M-454.31%

December 31, 2023


Summary


Performance

AGRX Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherAGRXbalance sheetmetrics:

Quarterly Working Capital

-$11.79 M
-$2.33 M-24.66%

June 1, 2024


Summary


Performance

AGRX Quarterly Working Capital Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

High & Low

Earnings dates

OtherAGRXbalance sheetmetrics:

Working Capital Formula

Working Capital = Current Assets − Current Liabilities

AGRX Working Capital Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterly
1 y1 year-454.3%0.0%
3 y3 years-122.8%0.0%
5 y5 years-280.2%0.0%

AGRX Working Capital Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs low
3 y3-year+454.3%at low-407.4%at low
5 y5-year-122.8%at low-112.8%at low
alltimeall time-122.8%at low-112.8%at low

Agile Therapeutics Working Capital History

DateAnnualQuarterly
Jun 2024
-
-$11.79 M(+24.7%)
Mar 2024
-
-$9.45 M(-15.9%)
Dec 2023
-$11.25 M(+454.3%)
-$11.25 M(+50.5%)
Sep 2023
-
-$7.47 M(+104.2%)
Jun 2023
-
-$3.66 M(-51.8%)
Mar 2023
-
-$7.60 M(+274.6%)
Dec 2022
-$2.03 M(-62.1%)
-$2.03 M(-152.9%)
Sep 2022
-
$3.83 M(-137.2%)
Jun 2022
-
-$10.31 M(-10.3%)
Mar 2022
-
-$11.50 M(+114.8%)
Dec 2021
-$5.35 M(-110.8%)
-$5.35 M(-143.9%)
Sep 2021
-
$12.19 M(-51.8%)
Jun 2021
-
$25.31 M(-27.4%)
Mar 2021
-
$34.89 M(-29.4%)
Dec 2020
$49.43 M(+56.8%)
$49.43 M(-25.2%)
Sep 2020
-
$66.11 M(-19.6%)
Jun 2020
-
$82.27 M(-10.4%)
Mar 2020
-
$91.79 M(+191.2%)
Dec 2019
$31.52 M(+405.2%)
$31.52 M(+77.2%)
Sep 2019
-
$17.79 M(+97.9%)
Jun 2019
-
$8.99 M(-15.2%)
Mar 2019
-
$10.60 M(+69.8%)
DateAnnualQuarterly
Dec 2018
$6.24 M(-72.2%)
$6.24 M(-32.5%)
Sep 2018
-
$9.24 M(-24.9%)
Jun 2018
-
$12.31 M(-26.1%)
Mar 2018
-
$16.66 M(-25.7%)
Dec 2017
$22.44 M(-44.7%)
$22.44 M(-34.0%)
Sep 2017
-
$34.01 M(+40.3%)
Jun 2017
-
$24.24 M(-25.8%)
Mar 2017
-
$32.68 M(-19.4%)
Dec 2016
$40.55 M(+33.8%)
$40.55 M(-12.6%)
Sep 2016
-
$46.40 M(-9.4%)
Jun 2016
-
$51.18 M(-14.9%)
Mar 2016
-
$60.12 M(+98.4%)
Dec 2015
$30.30 M(-5.3%)
$30.30 M(-10.1%)
Sep 2015
-
$33.72 M(-19.7%)
Jun 2015
-
$41.99 M(-15.2%)
Mar 2015
-
$49.55 M(+54.9%)
Dec 2014
$31.99 M(-798.8%)
$31.99 M(-19.6%)
Sep 2014
-
$39.81 M(-18.5%)
Jun 2014
-
$48.85 M(-1119.6%)
Mar 2014
-
-$4.79 M(+4.7%)
Dec 2013
-$4.58 M(-125.2%)
-$4.58 M
Dec 2012
$18.16 M
-

FAQ

  • What is Agile Therapeutics annual working capital?
  • What is the all time high annual working capital for Agile Therapeutics?
  • What is Agile Therapeutics annual working capital year-on-year change?
  • What is Agile Therapeutics quarterly working capital?
  • What is the all time high quarterly working capital for Agile Therapeutics?
  • What is Agile Therapeutics quarterly working capital year-on-year change?

What is Agile Therapeutics annual working capital?

The current annual working capital of AGRX is -$11.25 M

What is the all time high annual working capital for Agile Therapeutics?

Agile Therapeutics all-time high annual working capital is $49.43 M

What is Agile Therapeutics annual working capital year-on-year change?

Over the past year, AGRX annual working capital has changed by -$9.22 M (-454.31%)

What is Agile Therapeutics quarterly working capital?

The current quarterly working capital of AGRX is -$11.79 M

What is the all time high quarterly working capital for Agile Therapeutics?

Agile Therapeutics all-time high quarterly working capital is $91.79 M

What is Agile Therapeutics quarterly working capital year-on-year change?

Over the past year, AGRX quarterly working capital has changed by $0.00 (0.00%)